Yuji Shimura

シムラユウジ | Yuji Shimura

Affiliation and department：

Research field (1)： Hematology and oncology

Research keywords (1)： hematology

Research theme for competitive and other funds (2)：

2022 - 2025 miRNA inhibitor cocktail for suppressing MDSC function in hematologic malignancy
2018 - 2021 Molecular mechanisms underlying the induction of myeloid-derived suppressor cells in multiple myeloma

Papers (149)：

Yutaka Shimazu, Junya Kanda, Yoshiyuki Onda, Shin-Ichi Fuchida, Kensuke Ohta, Yuji Shimura, Satoru Kosugi, Ryosuke Yamamura, Mitsuhiro Matsuda, Hitoshi Hanamoto, et al. The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients. Cancer immunology, immunotherapy : CII. 2024. 73. 7. 135-135
Wakana Hashiro, Akihiro Miyashita, Yuka Kawaji-Kanayama, Haruya Okamoto, Takahiro Fujino, Taku Tsukamoto, Shinsuke Mizutani, Yuji Shimura, Junya Kuroda. Good's Syndrome With Pure Red Cell Aplasia and Subclinical Myasthenia Gravis: A Case Report and Review of Literature. Cureus. 2024. 16. 5. e59654
Naokazu Nakamura, Nobuyoshi Arima, Teruhito Takakuwa, Satoshi Yoshioka, Kazunori Imada, Kentaro Fukushima, Masaaki Hotta, Shin-Ichi Fuchida, Junya Kanda, Nobuhiko Uoshima, et al. Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study. Annals of hematology. 2024
Daisuke Ide, Takahiro Fujino, Tsutomu Kobayashi, Aya Egashira, Akihiro Miyashita, Kentaro Mizuhara, Reiko Isa, Taku Tsukamoto, Shinsuke Mizutani, Hitoji Uchiyama, et al. Prognostic model for relapsed/refractory transplant-ineligible diffuse large B-cell lymphoma utilizing the lymphocyte-to-monocyte ratio. International journal of hematology. 2024
Yu Inoue, Haruya Okamoto, Akihiro Miyashita, Yuka Kawaji-Kanayama, Shotaro Chinen, Takahiro Fujino, Taku Tsukamoto, Yuji Shimura, Shinsuke Mizutani, Hiroto Kaneko, et al. Clinical impacts of severe thrombocytopenia in the first cycle of azacitidine monotherapy and cytogenetics in patients with myelodysplastic syndrome: The Kyoto Conditional Survival Scoring System. Oncology letters. 2024. 27. 2. 62-62

ｍore...

MISC (84)：

羽白稚菜, 宮下明大, 水原健太郎, 金山悠加, 藤野貴大, 塚本拓, 水谷信介, 志村勇司, 黒田純也. 赤芽球癆と潜在性重症筋無力症を合併したGood症候群. 臨床血液. 2024. 65. 2
小倉圭史, 藤野貴大, 知念祥太郎, 宮下明大, 金山悠加, 塚本拓, 水谷信介, 志村勇司, 黒田純也. ベネトクラクス・リツキシマブ(VR)併用療法が奏効したRichter症候群. 臨床血液. 2023. 64. 2
加藤大思, 服部雄, 藤野貴大, 大西朗生, 塚本拓, 岡本明也, 前倉知佳, 長田浩明, 伊佐怜子, 木元弥生, et al. Extranodal NK/T-cell lymphoma with CNS invasion successfully treated with RIST. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 44th
宮下明大, 知念祥太郎, 小倉圭史, 村尾泰一, 井上祐, 新山侑生, 井出大輔, 長田浩明, 岡本明也, 村松彩子, et al. Management of adverse events with Tisagenlecleucel for relapsed/refractory large B cell lymphomas. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 45th
知念祥太郎, 宮下明大, 小倉圭史, 村尾泰一, 井上祐, 新山侑生, 井出大輔, 長田浩明, 岡本明也, 村松彩子, et al. Tisagenlecleucel for refractory large B cell lymphomas in Kyoto Prefectural University of Medicine. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 45th

ｍore...

Education (3)：

2009 - 2013 Kyoto Prefectural University of Medicine Graduate School of Medical Science
2000 - 2006 Kyoto Prefectural University of Medicine
1995 - 1999 Kyoto University Faculty of Pharmaceutical Sciences

Work history (8)：

2022/04 - 現在 Kyoto Prefectural University of Medicine
2021/04 - 2022/03 Kyoto Prefectural University of Medicine Hematology and Oncology
2017/01 - 2021/03 Kyoto Prefectural University of Medicine
2016/04 - 2016/12 Kyoto Prefectural University of Medicine
2013/04 - 2016/03 Kyoto Prefectural University of Medicine

Show all

Association Membership(s) (6)：

THE JAPANESE SOCIETY OF HEMATOLOGY , 日本リンパ網内系学会 , 日本臨床腫瘍学会 , 日本造血細胞移植学会 , 日本輸血・細胞治療学会 , 日本内科学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page